Research Article

GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma

Figure 4

Tumor development. Tumor size in mice inoculated with BMDCs matured with TNFα and treated with MAGE-AX, GK-1, or MAGE-AX/GK-1. From day 22 to day 24 the group treated with MAGE/GK-1 BMDCs had less tumor growth in comparison with all groups. From day 26 no tumor growth was shown in the TNFα and untreated groups, because the survival rate was 0%. Tumor growth of the MAGE-AX and GK-1 groups was similar. Without treatment (WT). Mean ± SEM . MAGE/GK-1 versus MAGE, MAGE/GK-1 versus GK-1, MAGE/GK-1 versus TNF, MAGE/GK-1 versus WT.